Vulnerability Description
nfs.ext in IBM AIX 5.3.x through 5.3.9 and 6.1.0 through 6.1.2 does not properly use the nfs_portmon setting, which allows remote attackers to bypass intended access restrictions for NFSv4 shares via unspecified vectors.
CVSS Score
10.0
HIGH
AV:N/AC:L/Au:N/C:C/I:C/A:C
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Ibm | Aix | 5.3.0 |
References
- http://aix.software.ibm.com/aix/efixes/security/nfs4_advisory.ascPatchVendor Advisory
- http://www-01.ibm.com/support/docview.wss?uid=isg1IZ49024Vendor Advisory
- http://www-01.ibm.com/support/docview.wss?uid=isg1IZ49096Vendor Advisory
- http://www-01.ibm.com/support/docview.wss?uid=isg1IZ49278
- http://www-01.ibm.com/support/docview.wss?uid=isg1IZ50399Vendor Advisory
- http://www-01.ibm.com/support/docview.wss?uid=isg1IZ50444Vendor Advisory
- http://www-01.ibm.com/support/docview.wss?uid=isg1IZ50496Vendor Advisory
- http://www.securityfocus.com/bid/36544Patch
- http://www.vupen.com/english/advisories/2009/2788Vendor Advisory
- https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3
- http://aix.software.ibm.com/aix/efixes/security/nfs4_advisory.ascPatchVendor Advisory
- http://www-01.ibm.com/support/docview.wss?uid=isg1IZ49024Vendor Advisory
- http://www-01.ibm.com/support/docview.wss?uid=isg1IZ49096Vendor Advisory
- http://www-01.ibm.com/support/docview.wss?uid=isg1IZ49278
- http://www-01.ibm.com/support/docview.wss?uid=isg1IZ50399Vendor Advisory
FAQ
What is CVE-2009-3517?
CVE-2009-3517 is a vulnerability with a CVSS score of 10.0 (HIGH). nfs.ext in IBM AIX 5.3.x through 5.3.9 and 6.1.0 through 6.1.2 does not properly use the nfs_portmon setting, which allows remote attackers to bypass intended access restrictions for NFSv4 shares via ...
How severe is CVE-2009-3517?
CVE-2009-3517 has been rated HIGH with a CVSS base score of 10.0/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2009-3517?
Check the references section above for vendor advisories and patch information. Affected products include: Ibm Aix.